Galina Tsykunova
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia.
Journal: Haematologica
Published: April 09, 2026
Progression-Free and Overall Survival After KRd Consolidation in FDG PET/CT Positive Patients After ASCT: A Phase II Study (CONPET).
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 14, 2025
Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma.
Journal: Blood cancer journal
Published: August 19, 2025
Safety and efficacy of daratumumab in immune thrombocytopenia.
Journal: Blood advances
Published: May 28, 2025
Relapse of Acute Myeloid Leukemia With Concomitant Systemic Mastocytosis Five Years Post Allogenic Hematopoietic Stem Cell Transplantation.
Journal: Case reports in hematology
Published: May 27, 2025
Factors associated with response to rituximab in patients with immune thrombocytopenia.
Journal: HemaSphere
Published: May 12, 2025
Infectious complications and the utility of serum and cellular markers of infections in the setting of allogeneic hematopoietic stem cell transplantation.
Journal: Expert review of clinical immunology
Published: January 06, 2025
MicroRNA-199a-5p may be a diagnostic biomarker of primary ITP.
Journal: British journal of haematology
Published: October 21, 2024
Bone marrow aspirate or biopsy for multiple myeloma: when percentages matter!
Journal: Expert review of hematology
Published: July 22, 2024
Adult presentation of ornithine transcarbamylase deficiency: a possible cause of hyperammonemia after high-dose chemotherapy and stem cell transplantation.
Journal: Hematology (Amsterdam, Netherlands)
Published: December 11, 2023
IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy.
Journal: Journal of clinical medicine
Published: March 22, 2022
Last Updated: 09/26/2026